A Passion for Science and a Commitment to Dermatology Dermavant Sciences is a specialty biopharmaceutical company developing innovative prescription therapies for dermatologic diseases. Dermavant has acquired promising compounds that address unmet therapeutic needs and has rapidly established a robust dermatology R&D pipeline. We are dedicated to realizing the full potential of biomedical research and to developing and commercializing novel first-in-class or best-in-class therapies that improve patients’ lives. The patient is at the heart of everything we do.
View Top Employees from Dermavant SciencesWebsite | http://www.dermavant.com |
Revenue | $4 million |
Funding | $200 million |
Employees | 301 (291 on RocketReach) |
Founded | 2016 |
Address | 3780 Kilroy Airport Way Suite 250, Long Beach, California 90806, US |
Phone | (919) 767-3277 |
Technologies |
JavaScript,
HTML,
PHP
+35 more
(view full list)
|
Industry | Biotechnology Research, Medical Testing & Clinical Laboratories, Healthcare |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54138 Companies, NAICS Code 5413 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Dermavant Sciences employee's phone or email?
The Dermavant Sciences annual revenue was $4 million in 2024.
Todd Zavodnick is the CEO of Dermavant Sciences.
291 people are employed at Dermavant Sciences.
Dermavant Sciences is based in Long Beach, California.
The NAICS codes for Dermavant Sciences are [54138, 5413, 541, 54].
The SIC codes for Dermavant Sciences are [873, 87].